A research platform that identifies non-pathogenic Fusarium strains compatible with UK pathogen populations to act as vectors for mycoviral biocontrol. By profiling heterokaryon incompatibility loci, the approach overcomes genetic barriers limiting mycoviral spread, enabling targeted biocontrol of soilborne fungal diseases.
Soilborne fungal pathogens cause significant crop losses globally, and conventional chemical controls face increasing regulatory and resistance challenges. This research addresses a key bottleneck in mycoviral biocontrol: the natural genetic barriers that restrict virus transmission between fungal individuals. Mycoviruses can induce hypovirulence in plant-pathogenic fungi, but they require hyphal fusion for transmission, making compatibility between donor and recipient strains essential.
The platform profiles heterokaryon incompatibility (het) loci across UK Fusarium populations to identify non-pathogenic Fusarium strains that are compatible with target pathogen populations. These compatible strains can then serve as vectors, delivering mycoviruses that disarm fungal pathogens and reduce disease. The approach combines population genomics, mycoviral discovery, and targeted vector identification to enable precision biocontrol of soilborne diseases.
Core capabilities:
Scientific basis:
The research team has demonstrated expertise in genomic analysis of pathogenic and mycoprotein-producing Fusarium species, including identification and annotation of heterokaryon incompatibility genes throughout Fusarium genomes. Preliminary analysis revealed that 16% of 805 Fusarium RNA-Seq datasets contain viral sequences, with 8.5% showing homology to known mycoviruses, confirming both the prevalence and diversity of exploitable mycoviruses in UK populations.
This research is at an early-to-mid stage of development. Current work has established the genomic foundation, including het gene identification and annotation across Fusarium genomes, and has confirmed widespread mycoviral presence in UK Fusarium populations. The next phase involves systematic population sampling, het gene diversity profiling, barrier identification through PCR screening, and proof-of-concept transmission studies using compatible non-pathogenic vectors. Validation will progress from laboratory characterisation through to demonstration of mycoviral transmission and hypovirulence induction in UK Fusarium populations.
The University of Greenwich is a comprehensive public university spanning campuses in London and Medway, combining professional education with applied research for industry collaboration. Its Medway campus, shared with the Universities of Kent and Canterbury Christ Church, concentrates engineering and science in refurbished dockyard facilities with large, modern laboratories and test spaces, enabling access to equipment and co‑located expertise. The university’s Natural Resources Institute and the Medway Food & Innovation Centre provide industry‑accessible facilities for product development, validation, training, and consultancy. Research is supported by UK Research and Innovation, including Innovate UK, alongside other competitive public funders. A dedicated technology transfer office supports IP, licensing, KTP delivery, and startup support to streamline engagement for corporate partners.